13D Management’s Elanco Animal Health ELAN Stock Holding History

13D Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-495,622	Closed	-$8.07M	–	25
2024 Q1	$8.07M	Buy	+495,622	New	+$7.75M	4.93%	5
2022 Q4	–	Sell	-296,839	Closed	-$3.68M	–	30
2022 Q3	$3.68M	Sell	296,839 -56,444	-16%	-$987K	1.93%	27
2022 Q2	$6.93M	Buy	353,283 +21,961	+7%	+$520K	3.07%	17
2022 Q1	$8.64M	Sell	331,322 -29,272	-8%	-$780K	3.29%	12
2021 Q4	$10.2M	Sell	360,594 -22,116	-6%	-$688K	3.92%	11
2021 Q3	$12.2M	Hold	382,710	–	–	4.54%	6
2021 Q2	$13.3M	Buy	382,710 +82,600	+28%	+$2.72M	4.57%	3
2021 Q1	$8.84M	Buy	300,110 +26,110	+10%	+$803K	3.27%	17
2020 Q4	$8.4M	Buy	+274,000	New	+$8.36M	3.47%	13

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

13D Management's ELAN Position: Q2 2024 in Review

13D Management sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 495,622 shares — an estimated $8.07M sold.

13D Management first reported a position in ELAN in Q4 2020 and held it in 9 quarters. The position peaked at $13.3M in Q2 2021. 403 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

13D Management reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
13D Management sold 495,622 Elanco Animal Health shares in Q2 2024, an estimated $8.07M.
13D Management first reported a position in Elanco Animal Health in Q4 2020 and held it in 9 quarters.
13D Management's Elanco Animal Health position peaked at $13.3M in Q2 2021.
403 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on 13D Management's 13F filing for Q2 2024, filed 14 Aug 2024.